INTERMEDIATE REPORT OF A FASE I-II STUDY OF HIGH DOSE HYPOFRACTIONATED TOMOTHERAPY FOR LOCALIZED PROSTATE CANCER: PROMISINGLY HIGH BIOCHEMICAL CONTROL WITH MINIMAL RATE OF GRADE 3 TOXICITY